Overall Abstract of the Program Endothelial barrier dysfunction is a central factor in the pathogenesis of protein-rich lung edema formation and lung inflammation, the hallmarks of acute respiratory distress syndrome (ARDS). Due to the complexity of these conditions, attempts to develop drugs and cell-based therapies have thus far not been successful. Thus, whereas previously explored therapeutics specifically targeted the complex multistep process that occurs during the lung injury phase, here we propose to focus on processes underlying the resolution of vascular leakage and pulmonary edema. The central hypothesis of the Program Project application for years 16 to 20 is that resealing of the endothelial barrier at the level of adherens junctions (AJs) is required to restore junctional integrity, and thereby to normalize lung fluid balance. The research focus in all Projects will thus be on delineating the role of overlapping but specialized signaling pathways that operate to re-seal AJs, and on this basis, identifying novel therapeutic targets that can be harnessed to reverse the course of the disease. In Project 1, Dr. Asrar Malik, PI, will test the novel hypothesis that restoration of lung endothelial barrier is regulated by two complementary mechanisms, the vascular endothelial protein tyrosine phosphatase (VE-PTP)-mediated stabilization of VE-cadherin, and the Rac1-mediated formation of adhesive bonds between VE-cadherin molecules at AJs. These studies will define the signaling mechanisms activated by VE-PTP interaction with VE-cadherin, and with tyrosine kinase receptor Tie2 in regulating the integrity of the lung endothelial barrier. In Project 2, Dr. Jalees Rehman, PI, will test the central hypothesis that inflammation-induced glycolysis in lung endothelial cells (ECs) is an intrinsic mechanism necessary for restoration of endothelial barrier function. Studies will examine the roles of the key rate-limiting kinase in regulating glycolysis 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase3 (PFK-FB3), and activation of glutamine metabolism in mitochondria in endothelial barrier repair. In Project 3, Dr. Dolly Mehta, PI, will test the fundamental hypothesis that S1P receptor-1 (S1PR1) expression regulates lung vascular barrier integrity, and is essential for restoring lung fluid balance. These studies will define mechanisms controlling the cell surface expression of S1PR1 in ECs following lung injury, and the role of interaction of S1PR1 with the VEGF receptor (VEGFR2) in establishing vascular endothelial integrity. In Project 4, Dr. Viswanathan Natarajan, PI, will test the hypothesis that spatial and coordinated production of lipid second messengers such as phosphatidic acid by phospholipase D2 (PLD2) and of S1P by sphingosine kinase 1 (SphK1) is required for lamellipodia formation and recycling of VE-cadherin to AJs to restore the EC barrier. These studies will define the function of these bioactive lipids as key mediators inducing the formation of AJs, and thereby the endothelial barrier integrity and how their function can be optimized to restore lung-fluid balance. We posit that this concerted effort using novel and rigorous approaches described in each project of the Program, will lay new conceptual groundwork for identifying novel therapeutic targets to treat ARDS.

Public Health Relevance

Program Narrative Acute respiratory distress syndrome (ARDS) is a consequence of systemic inflammatory conditions such as sepsis that compromise host-defense mechanisms, and result in increased capillary leakage that leads to influx of protein-rich fluid into the lung. This Program Project renewal application seeks to define intrinsic evolutionary conserved signaling mechanisms that are responsible for maintaining and restoring the integrity of lung endothelial barrier function. Elucidating these mechanisms will lead to identification of novel therapeutic targets that can be harnessed to reverse the course of the disease.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Program Projects (P01)
Project #
5P01HL060678-19
Application #
9730550
Study Section
Special Emphasis Panel (ZHL1)
Program Officer
Xiao, Lei
Project Start
2000-03-08
Project End
2021-06-30
Budget Start
2019-07-01
Budget End
2020-06-30
Support Year
19
Fiscal Year
2019
Total Cost
Indirect Cost
Name
University of Illinois at Chicago
Department
Pharmacology
Type
Schools of Medicine
DUNS #
098987217
City
Chicago
State
IL
Country
United States
Zip Code
60612
Marsboom, Glenn; Rehman, Jalees (2018) Hypoxia Signaling in Vascular Homeostasis. Physiology (Bethesda) 33:328-337
Lv, Yang; Kim, Kyungho; Sheng, Yue et al. (2018) YAP Controls Endothelial Activation and Vascular Inflammation Through TRAF6. Circ Res 123:43-56
Christoforidis, Theodore; Driver, Tom G; Rehman, Jalees et al. (2018) Generation of controllable gaseous H2S concentrations using microfluidics. RSC Adv 8:4078-4083
Di, Anke; Xiong, Shiqin; Ye, Zhiming et al. (2018) The TWIK2 Potassium Efflux Channel in Macrophages Mediates NLRP3 Inflammasome-Induced Inflammation. Immunity 49:56-65.e4
Chen, Zhenlong; D S Oliveira, Suellen; Zimnicka, Adriana M et al. (2018) Reciprocal regulation of eNOS and caveolin-1 functions in endothelial cells. Mol Biol Cell 29:1190-1202
Le Master, Elizabeth; Huang, Ru-Ting; Zhang, Chongxu et al. (2018) Proatherogenic Flow Increases Endothelial Stiffness via Enhanced CD36-Mediated Uptake of Oxidized Low-Density Lipoproteins. Arterioscler Thromb Vasc Biol 38:64-75
Mittal, Manish; Nepal, Saroj; Tsukasaki, Yoshikazu et al. (2017) Neutrophil Activation of Endothelial Cell-Expressed TRPM2 Mediates Transendothelial Neutrophil Migration and Vascular Injury. Circ Res 121:1081-1091
Yamada, Kaori H; Kang, Hojin; Malik, Asrar B (2017) Antiangiogenic Therapeutic Potential of Peptides Derived from the Molecular Motor KIF13B that Transports VEGFR2 to Plasmalemma in Endothelial Cells. Am J Pathol 187:214-224
Rexius-Hall, Megan L; Rehman, Jalees; Eddington, David T (2017) A microfluidic oxygen gradient demonstrates differential activation of the hypoxia-regulated transcription factors HIF-1? and HIF-2?. Integr Biol (Camb) 9:742-750
Robinson, Tanisha M; Jicsinszky, Laszlo; Karginov, Andrei V et al. (2017) Inhibition of Clostridium perfringens epsilon toxin by ?-cyclodextrin derivatives. Int J Pharm 531:714-717

Showing the most recent 10 out of 200 publications